The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Variables impacting the number of palliative chemotherapy lines administered to patients with advanced non-small cell lung cancer (NSCLC) in a common daily practice setting.
Diana Marcela Roa-Garcia
No relevant relationships to disclose
Silvia Muñoz
No relevant relationships to disclose
Neus Baste
No relevant relationships to disclose
Francia Holguin
No relevant relationships to disclose
Elia Sais
No relevant relationships to disclose
Cristina Urbano
No relevant relationships to disclose
Nuri Quer
No relevant relationships to disclose
Silvia Guerra
No relevant relationships to disclose
Silvia Cufi
No relevant relationships to disclose
Alejandro Vazquez-Martin
No relevant relationships to disclose
Cristina Oliveras-Ferraros
No relevant relationships to disclose
Bruna Corominas-Faja
No relevant relationships to disclose
Javier A. Menendez
No relevant relationships to disclose
Joan Brunet
No relevant relationships to disclose
Adelaida Garcia-Velasco
No relevant relationships to disclose
Angel Izquierdo
No relevant relationships to disclose
Rut Porta
No relevant relationships to disclose
Joaquim Bosch-Barrera
No relevant relationships to disclose